Biomarkers in Olink Oncology II

• 5'-nucleotidase (5'-NT)
• A disintegrin and metalloproteinase with thrombospondin motifs 15 (ADAM-TS 15)
• Alpha-taxilin (TXLNA)
• Amphiregulin (AREG)
• Annexin A1 (ANXA1)
• C-type lectin domain family 4 member K (CD207)
• C-X-C motif chemokine 13 (CXCL13 )
• Carbonic anhydrase IX (CAIX)
• Carboxypeptidase E (CPE)
• Carcinoembryonic antigen (CEA)
• Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1)
• Cathepsin L2 (CTSV)
• CD160 antigen (CD160)
• CD27 antigen (CD27)
• CD48 antigen (CD48)
• CD70 antigen (CD70)
• Cornulin (CRNN)
• Cyclin-dependent kinase inhibitor 1 (CDKN1A)
• Delta-like protein 1 (DLL1)
• Disintegrin and metalloproteinase domain-containing protein 8 (ADAM8)
• Endothelial cell-specific molecule 1 (ESM-1)
• Ephrin type-A receptor 2 (EPHA2)
• Fas antigen ligand (FasL)
• FAS-associated death domain protein (FADD)
• Fc receptor-like B (FCRLB)
• Fibroblast growth factor-binding protein 1 (FGF-BP1)
• Folate receptor alpha (FR-alpha)
• Folate receptor gamma (FR-gamma)
• Furin (FUR)
• Galectin-1 (Gal-1)
• Glypican-1 (GPC1)
• Granzyme B (GZMB)
• Granzyme H (GZMH)
• Hepatocyte growth factor (HGF)
• ICOS ligand (ICOSLG)
• Insulin-like growth factor 1 receptor (IGF1R)
• Integrin alpha-V (ITGAV)
• Integrin beta-5 (ITGB5)
• Interferon gamma receptor 1 (IFN-gamma-R1)
• Interleukin-6 (IL6)
• Kallikrein-11 (hK11)
• Kallikrein-13 (KLK13)
• Kallikrein-14 (hK14)
• Kallikrein-8 (hK8)
• Ly6/PLAUR domain-containing protein 3 (LYPD3)
• Melanoma-derived growth regulatory protein (MIA)
• Mesothelin (MSLN)
• Methionine aminopeptidase 2 (MetAP 2)
• MHC class I polypeptide-related sequence A/B (MIC-A/B)
• Midkine (MK)
• Mothers against decapentaplegic homolog 5 (MAD homolog 5)
• Mucin-16 (MUC-16)
• Nectin-4 (PVRL4)
• Pancreatic prohormone (PPY)
• Podocalyxin (PODXL)
• Pro-epidermal growth factor (EGF)
• Protein CYR61 (CYR61)
• Protein S100-A11 (S100A11)
• Protein S100-A4 (S100A4)
• Proto-oncogene tyrosine-protein kinase receptor Ret (RET)
• R-spondin-3 (RSPO3)
• Receptor tyrosine-protein kinase erbB-2 (ErbB2/HER2)
• Receptor tyrosine-protein kinase erbB-3 (ErbB3/HER3)
• Receptor tyrosine-protein kinase erbB-4 (ErbB4/HER4)
• Secretory carrier-associated membrane protein 3 (SCAMP3)
• Seizure 6-like protein (SEZ6L)
• SPARC (SPARC)
• Stem cell factor (SCF)
• Syndecan-1 (SYND1)
• T-cell leukemia / lymphoma protein 1A (TCL1A)
• T-lymphocyte surface antigen Ly-9 (LY9)
• TGF-beta receptor type-2 (TGFR-2)
• Tissue factor pathway inhibitor 2 (TFPI-2)
• TNF-related apoptosis-inducing ligand (TRAIL)
• Toll-like receptor 3 (TLR3)
• Transforming growth factor alpha (TGF-alpha)
• Transmembrane glycoprotein NMB (GPNMB)
• Tumor necrosis factor ligand superfamily member 13 (TNFSF13)
• Tumor necrosis factor receptor superfamily member 19 (TNFRSF19)
• Tumor necrosis factor receptor superfamily member 4 (TNFRSF4 )
• Tumor necrosis factor receptor superfamily member 6B (TNFRSF6B)
• Tyrosine-protein kinase ABL1 (ABL1)
• Tyrosine-protein kinase Lyn (LYN)
• Vascular endothelial growth factor A (VEGF-A)
• Vascular endothelial growth factor receptor 2 (VEGFR-2)
• Vascular endothelial growth factor receptor 3 (VEGFR-3)
• VEGF-co regulated chemokine 1 (CXCL17)
• Vimentin (VIM)
• WAP four-disulfide core domain protein 2 (WFDC2)
• Wnt inhibitory factor 1 (WIF-1)
• WNT1-inducible-signaling pathway protein 1 (WISP-1)
• Xaa-Pro aminopeptidase 2 (XPNPEP2)